This month’s Back to Basics feature is a summary of the sites of action and pharmacology of the main direct oral anticoagulants (DOACs). These drugs are becoming a standard therapy in many settings including stroke prevention, management of deep vein thrombosis and pulmonary embolism, and prevention of venous thromboembolism following hip and knee replacement.
Other related articles
Using NOACs for stroke prevention in atrial fibrillation
Using the novel oral anticoagulants in primary care
AF and stroke prevention: case finding in primary care
